Skip to main content
. Author manuscript; available in PMC: 2015 Aug 28.
Published in final edited form as: J Gastroenterol Hepatol. 2013 Oct;28(10):1660–1668. doi: 10.1111/jgh.12291

Figure 2.

Figure 2

Increased hepatic steatosis in experimental chronic alcohol-relaed liver disease—effects of myriocin treatment. Cryostat sections of paraformaldehydefixed livers from (a) control + vehicle, (b) control + myriocin, (c) ethanol + vehicle, and (d) ethanol + myriocin groups were stained with Oil Red O to detect cytoplasmic lipid accumulation (red punctate or vesicular labeling—inset in c).